TIM-3 expression on immune cells has been reported to be associated with disease activity and prognosis in multiple types of cancers, e.g. AML (13), pediatric B-precursor acute lymphoid leukemia (14), lung cancer (2, 4). The gene discussed is HAVCR2; the disease is cancer.